Wednesday 16 July 2014    10:30 – 12:00
Track 1 - Novel drug targets in oncology

Chair: 

NVP-AUY922 and Rapamycin Synergistically Enhances Autophagy-Mediated KIT Degradation and Cell Deaths in Imatinib-Refractory Gastrointestinal Stromal Tumors
Yuan-Shuo Hsueh

Adenosine A1 receptor-mediated regulation of equilibrative nucleoside transporter 1 (ENT1) activity via protein kinase C.
James Hammond

Pharmacological Levels of Withaferin A (Withania somnifera) suppress invasion concomitantly with epigenetic silencing of prometastatic gene expression  in triple negative breast cancer cells
Wim Vanden Berghe

Angiogenesis of lung stem/progenitor cells in a three-dimensional scaffold
Thai-yen Ling

Blocking M2 muscarinic receptor signaling inhibits tumor growth and reverses epithelial-mesenchymal transition (EMT) in non-small cell lung cancer (NSCLC)
Lu Xu

IL6/IGF-IR Signal Maintains Stemness Expression and Early Recurrence of HBV-Related Hepatocellular Carcinoma
Yen-Hua Huang

Preclinical trial of botulinum toxin type A for treatment of gastric Cancer
Chun-Mei Zhao 

South African Society for Basic and Clinical Pharmacology Section 21 Company, Registration no. 2006/029963/08 Registry Office: Alchemy Financial Services Unit 3 Bush Hill Office Park, Jan Frederick Ave, Honeydew 2154

© Scatterlings Conference and Events